845 results
·
29ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Somatic Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·therascreen PDGFRA RGQ PCR Kit
Prosthesis, Hip, Hemi-, Acetabular, Cemented, Metal
FDA classification
FDA Class 3
·Prosthesis, Hip, Hemi-, Acetabular, Cemented, Metal
Prosthesis, Hip, Pelvifemoral Resurfacing, Metal/Polymer
FDA classification
FDA Class 3
·Prosthesis, Hip, Pelvifemoral Resurfacing, Metal/Polymer
Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
FDA classification
FDA Class 3
·Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
Immunohistochemistry Assay, Antibody, Ki-67
FDA Pre-Market Approval
FDA Class 3
·Ki-67 IHC pharmDx
Immunohistochemistry Assay, Antibody, Met
FDA Pre-Market Approval
FDA Class 3
·VENTANA MET (SP44) RxDx Assay
Immunohistochemistry Assay, Antibody, Claudin 18
FDA Pre-Market Approval
FDA Class 3
·VENTANA CLDN18 (43-14A) RxDx Assay
Somatic Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·Roche cobas DNA Sample Preparation Kit, COBAS 4800 BRAF V600 MUTATION TEST
Immunohistochemistry Assay, Antibody, Folr1
FDA Pre-Market Approval
FDA Class 3
·VENTANA FOLR1 (FOLR-2.1) RxDx Assay
Cancer-Related Germline Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·myChoice HRD CDx
Somatic Gene Mutation Detection System
FDA Pre-Market Approval
FDA Class 3
·THERASCREEN EGFR RGQ PCR KIT
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·Oncomine Dx Express Test
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA Pre-Market Approval
FDA Class 3
·INFORM HER2 DUAL ISH DNA PROBE COCKTAIL
System, Test, Her-2/Neu, Ihc
FDA Pre-Market Approval
FDA Class 3
·PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 PHARMDX
Prosthesis, Hip, Semi-Constrained, Metal/Metal, Resurfacing
FDA classification
FDA Class 3
·Prosthesis, Hip, Semi-Constrained, Metal/Metal, Resurfacing
Prosthesis, Hip, Pelvifemoral Resurfacing, Metal/Polymer, Uncemented
FDA classification
FDA Class 3
·Prosthesis, Hip, Pelvifemoral Resurfacing, Metal/Polymer, Uncemented
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA classification
FDA Class 3
·Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
Implantable Pulse Generator, Pacemaker (Non-Crt)
FDA Pre-Market Approval
FDA Class 3
·REVO MRI SURESCAN IPG AND PACING SYSTEM
Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
FDA Pre-Market Approval
FDA Class 3
·MI Cancer Seek